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Abstract
Introduction Sepsis is the main cause of morbidity and mortality
in intensive care units and its early diagnosis is not
straightforward. Many studies have evaluated the usefulness of
various markers of infection, including C-reactive protein (CRP),
which is the most accessible and widely used. CRP is of weak
diagnostic value because of its low specificity; a better
understanding of patterns of CRP levels associated with a
particular form of infection may improve its usefulness as a
sepsis marker. In the present article, we apply multilevel
modeling techniques and mixed linear models to CRP-related
data to assess the time course of CRP blood levels in
association with clinical outcome in children with different septic
conditions.
Methods We performed a retrospective analysis of 99 patients
with systemic inflammatory response syndrome, sepsis, or
septic shock who were admitted to the Pediatric Critical Care
Unit at the University Hospital, Brno. CRP blood levels were
monitored for 10 days following the onset of the septic
condition. The effect of different septic conditions and of the
surgical or nonsurgical diagnosis on CRP blood levels was
statistically analyzed using mixed linear models with a multilevel
modeling approach.
Results A significant effect of septic condition and diagnosis on
the course of CRP levels was identified. In patients who did not
progress to septic shock, CRP blood levels decreased rapidly
after reaching peak values – in contrast to the values in patients
with septic shock in whom CRP protein levels decreased slowly.
Moreover, CRP levels in patients with a surgical diagnosis were
higher than in patients with a nonsurgical condition. The
magnitude of this additional elevation in surgical patients did not
depend on the septic condition.
Conclusion Understanding the pattern of change in levels of
CRP associated with a particular condition may improve its
diagnostic and prognostic value in children with sepsis.
Introduction
Sepsis remains the main cause of morbidity and mortality in
intensive care units [1,2]. Host immunodeficiency, increasing
bacterial resistance to antibiotics, and problematic discrimina-
tion of an early onset of infection are the major factors altering
the course of infections [3,4]. Early diagnosis of sepsis and
consequently its correct treatment are fundamental to achiev-
ing a positive outcome for patients. Many studies have evalu-
ated the usefulness of various markers of infection in different
septic conditions – C-reactive protein (CRP), procalcitonin
(PCT), TNFα, and IL-6, IL-8, and IL-10 [5-9].
In clinical practice, CRP is the most accessible and widely
used marker of infection, and many authors have addressed its
sensitivity and specificity [5,10-14], some of whom compared
CRP levels among various diagnoses and/or severities of
organ dysfunction [13,14]. Various noninfectious insults, such
as trauma [15] or malignancy, can influence the levels of
CRP = C-reactive protein; DG = diagnosis effect; IL = interleukin; MODS = multiple organ dysfunction syndrome; NIN = noninfectious group; PCT 
= procalcitonin; SEP = effect of septic category; SIRS = systemic inflammatory response syndrome; SPT = septic group; SSM = shock and multiple 
organ dysfunction syndrome group; TNF = tumor necrosis factor.Critical Care    Vol 11 No 3    Kyr et al.
Page 2 of 9
(page number not for citation purposes)
inflammatory markers, especially CRP [16] – leading to a
decrease in the diagnostic value of CRP. Therefore CRP
seems to be a sensitive but less specific marker of infection.
Several studies have focused on how CRP levels change over
time to improve its diagnostic value [12-14,17,18]; however,
hardly any have involved a true longitudinal analysis of the data
to assess how various factors affect CRP levels. In our study,
we incorporated these considerations and analyzed our data
using a multilevel linear model with mixed effects [19-22].
Knowing the factors influencing CRP levels in sepsis as well
as the patterns of these levels associated with different medi-
cal or surgical conditions can lead to a better understanding
of its diagnostic value.
Materials and methods
Study population
We performed a retrospective study collecting data from
patients 0–18 years old participating in a gene polymorphism
study [23]. All pediatric patients whose parents or legal guard-
ians gave informed consent approved by an Institutional Ethics
Committee were included. Inclusion criteria for participation in
the study included admission to the pediatric critical care unit
at the University Hospital Brno, Brno, Czech Republic, for at
least 24 hours and a presence of systemic inflammatory
response syndrome (SIRS), sepsis, severe sepsis, septic
shock, or multiple organ dysfunction syndrome (MODS),
defined according to the consensus conference [24]. Patients
admitted to the pediatric critical care unit from September
2003 to December 2005 were enrolled.
If a patient was admitted to the pediatric critical care unit more
than once, only the first admission was considered. Each
patient was assessed for a septic condition each day of the
hospital stay. CRP blood levels were recorded, if present,
using a turbidimetry technique with a Hitachi 917 (Roche
Diagnostics, Basel, Switzerland) device. Each patient was
classified according to the presence of infection and to the
most severe septic condition that developed over the 10-day
period: noninfectious group (NIN), comprising SIRS, shock, or
MODS of noninfectious origin; septic group (SPT), comprising
sepsis or severe sepsis; or septic shock or MODS group
(SSM) in the presence of infection. The international pediatric
sepsis consensus criteria were used for patient classification
[24]. The 10-day period was considered as follows: for NIN
patients, day 0 was the first day of SIRS being present; in
patients with infection (SPT and SSM patients), day 0 was
considered the first day of SIRS in the course of infection.
Patients were further classified as surgical (major surgery or
trauma immediately preceding the septic condition) or
nonsurgical.
Statistical analysis
We used a graphical analysis to explore the dynamics of CRP
levels and to help identify the final model used. A logarithmic
transformation of the response variable 'CRP level' was per-
formed to achieve an approximately normal distribution, and
these transformed data were used in the analyses. A longitudi-
nal data analysis was performed using mixed models and mul-
tilevel modeling techniques. Unconditional means and growth
models, as well as two final conditional models, are presented
here. For the terminology of unconditional models we refer to
Singer and Willett [19]. Table 1 provides the model
specifications.
A two-level mixed linear model was applied. At level 1 of the
model, the response variable Y = ln(CRP) was considered a
quadratic function of time with random parameters for each
patient. We selected the quadratic function based on the
exploratory data analysis presented in Figure 1. At level 2 of
the model, the random parameters from model level 1 were
Table 1
Model specifications
Model Level 1 Level 2
Unconditional means model Yij = β0i + eij β0i = γ00 + u0i
Unconditional growth model Yij = β0i+ β1iTIMEij + β2i TIMEij*TIMEij + eij β0i = γ00 + u0i
β1i = γ10 + u1i
β2i = γ20 + u2i
Model A Yij = β0i+ β1iTIMEij + β2i TIMEij*TIMEij + eij β0i = γ00 + γ01SEPi + u0i
β1i = γ10 + γ11SEPi + u1i
β2i = γ20 + u2i
Model B Yij = β0i + β1iTIMEij + β2i TIMEij*TIMEij + eij β0i = γ00 + γ01SEPi + γ02DGi + u0i
β1i = γ10 + γ11SEPi + u1i
β2i = γ20 + u2iAvailable online http://ccforum.com/content/11/3/R70
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explained using a variance analysis model with fixed effects.
Two parameter models at level 2, A and B, were considered
according to the number of factors involved. Only one factor,
category of septic condition (SEP), with three levels (NIN,
SPT, SSM), was involved in model A. Two factors, SEP and
diagnosis (DG), with two categories (surgical, nonsurgical),
were involved in model B.
Table 1 presents the formal notation. Index i was used to iden-
tify a patient and index j to identify a repeated observation in
time. The variance components correspond to the variance of
the error term u from Table 1. The normal distributions of all
error terms have been assumed.
Analyses were performed using SAS 9.1 package (SAS Insti-
tute Inc., Cary, NC, USA). For mixed modeling, Proc Mixed
(SAS Institute Inc.) was used and a maximum likelihood esti-
mation method was adopted. The model fit was evaluated
according to Akaike's information criteria and Schwarz's infor-
mation criteria (smaller values indicate better fit).
Results
We collected data for a total of 99 patients with sufficient
records totaling 588 waves of CRP levels. The mean patient
age was 7.6 years (range, 0.1 to 18.5 years). Our sample pop-
ulation consisted of 65 males and 34 females, with 41 surgical
patients and 58 nonsurgical patients. The NIN comprised 32
patients who developed SIRS, only two of whom experienced
shock. All patients in the SPT had, by definition [24], severe
sepsis. In the SSM, 10 patients with septic shock and seven
patients with MODS were included. Table 2 summarizes the
numbers of patients in each diagnostic group. For more
detailed insight into the data, the mean age (standard devia-
tion) and clinical diagnoses of nonsurgical patients according
to the group analyzed are summarized in Tables 3 and 4,
respectively. The NIN patients were associated with 100%
survival of the pediatric critical care unit stay; the SPT patients
were associated with 4.2% mortality; and, as expected, the
highest mortality (35.3%) occurred in the SSM patients.
The fitted models and parameter estimates are presented in
Table 5. We present two unconditional and two final models.
Because the SEP and DG predictors take on three and two
discrete values, respectively, equations for the two full models
for respective septic and diagnosis categories can be rewrit-
ten as presented in Table 6.
The graphical representations of the models fitted are shown
in comparison with individual data (Figure 1) and in compari-
son with each septic or diagnosis category (Figure 2). For
ease of interpretation, raw values are also presented in the
graphs.
Figure 1
Individual C-reactive protein curves Individual C-reactive protein curves. Individual level (thin lines) and model level (bold lines) C-reactive protein (CRP) curves of the noninfectious 
group (left, green), the septic group (middle, blue), and the shock and multiple organ dysfunction syndrome group (right, red).
Table 2
Numbers of patients
Diagnosis
Category of severity Internal Surgical
Noninfectious group 72 7
Sepsis/severe sepsis group 37 11
Septic shock/multiple organ dysfunction syndrome group 14 3
Total 58 41Critical Care    Vol 11 No 3    Kyr et al.
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Discussion
Unconditional models
Fitting unconditional models enables quantification of the
overall variance present in our data [19,20]. Including
independent variables (predictors) in the model, we can
assess the reduction of the variance caused by an included
predictor; that is, explained variability accounted for the effect
of predictors. First, we fitted an unconditional means and
growth model (Table 5). The linear model was not significant
as soon as we estimated the intercept. We then identified the
quadratic model with significant effects. Comparing residual
variance from these two models, we found that a great deal of
explainable variation, almost 74%, could be explained by a
quadratic level 1 model of time (unconditional growth model).
CRP dynamics therefore provide a great deal of information.
We then included all level 2 independent variables and their
interactions. Estimates of interaction of diagnosis by septic
category, diagnosis by time, and diagnosis by septic category
by time were not significant predictors (data not shown).
Excluding these, we arrive at the two final models (Table 5).
Full model A
The first model (full model A) includes the septic category
(SEP) and the septic category by time interaction (SEP*TIME)
as predictors. This model indicates that baseline CRP levels
are lowest in the NIN; an average child without infection has a
baseline ln(CRP) = 2.33, peaking at approximately day 3 with
ln(CRP) = 3.07. In the SPT, however, baseline CRP levels are
higher; an average SPT child has a baseline ln(CRP) = 3.74,
peaking at approximately day 2 with ln(CRP) = 4.17 but
quickly decreasing with time. In the SSM, baseline CRP levels
were similar to those in the SPT (ln(CRP) = 3.36 for an aver-
age child with septic shock or MODS); contrary to the SPT,
however, the levels reached the maximum slightly later,
approximately day 4 (ln(CRP) = 4.43), and decreased less
rapidly.
We believe that the differences in baseline values of CRP lev-
els of the NIN patients versus the other two groups are the
result of the study design. We defined day 0 in a slightly differ-
ent way for the former group; thus, the onset of the CRP level
increase can result from different factors in the infectious
groups (SPT and SSM patients) and in the noninfectious
group. As Figure 2 illustrates, absolute values of CRP are
higher in the SPT and SSM, peaking at days 2 to 4, compared
with the values in the NIN. These findings are consistent with
those of other studies [13,14]. We, however, present another
consideration: the rate of decreasing CRP levels is slower in
the shock group than in the septic group.
Full model B
The second final model (full model B) includes an additional
predictor: a diagnosis dichotomy (internal or surgical). Includ-
ing this additional predictor, we obtained another model with
Table 3
Mean (standard deviation) age of patients
Diagnosis
Category of severity Internal Surgical
Noninfectious group 5.6 ± 6.5 8.2 ± 5.8
Sepsis/severe sepsis group 7.2 ± 5.9 10.8 ± 5.8
Septic shock/multiple organ dysfunction syndrome group 5.6 ± 5.8 9.3 ± 0.8
Table 4
Diagnoses of nonsurgical patients
Diagnosis Noninfectious group Sepsis/severe sepsis group Septic shock/multiple organ 
dysfunction syndrome group
Status epilepticus 2 6 2
Central nervous system 0 7 0
Respiratory 0 14 5
Cancer 0 1 4
O t h e r 593
Total 7 37 14Available online http://ccforum.com/content/11/3/R70
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a slightly lower score of information criteria (Akaike's informa-
tion criteria, 1,539.6 (model A) compared with 1,544.0 (model
B); and Schwarz's information criteria, 1,578.7 (model A)
compared with 1,580.5 (model B). This full model B indicates
that CRP levels are higher in surgical (or traumatic) patients
than in patients with an internal diagnosis. Owing to an insig-
nificant interaction of diagnosis with the septic category as
well as with time, we can conclude that the effect of surgical
diagnosis is, on a logarithmic scale, approximately the same
for each septic category and over time. The magnitude of this
additional elevation in surgical patients therefore does not
depend on septic condition. Computing the model equations
(Table 6), we can see that the differences in ln(CRP) levels at
their peaks between an average child with a nonsurgical diag-
nosis and one with a surgical diagnosis are 2.54 versus 3.2,
4.01 versus 4.67, and 4.3 versus 4.96 for the NIN, SPT, and
SSM, respectively.
C-reactive protein and other proinflammatory markers
Many authors target finding proinflammatory markers of infec-
tion and SIRS other than the CRP, such as PCT, IL-1, IL-6, or
TNFα [5-9,13,15,16]. Some of these studies [13,15,16] com-
pared PCT levels with CRP levels in septic patients, suggest-
ing that PCT can be a more reliable marker than CRP.
Table 5
Models fitted
Parameter Unconditional models Model A Model B
Means Growth
Linear Quadratic
Fixed effects
Initial status Intercept (γ00) 3.488*** 3.631*** 3.215*** 2.327*** 1.830***
Main effect SEP (γ01) *** ***
SSM 1.029 1.402
SPT 1.415 1.762
NIN 0 0
DG (γ02) *
Surgical 0.661
Nonsurgical 0
Rate of change TIME (γ10) -0.039NS 0.438*** 0.483*** 0.471***
TIME*TIME (γ20) -0.077*** -0.079*** -0.078***
Factorial SEP*TIME (γ11)* *
SSM 0.101 0.109
SPT -0.113 -0.104
NIN 0 0
DG*TIME NS/EX
SEP*DG NS/EX
SEP*DG*TIME NS/EX
Random effects (variance components)
Level 1 Residuals (var(eij) = σ2) 1.001*** 0.044*** 0.265*** 0.263*** 0.263***
Level 2 Intercept (var(u0i) = σ00) 1.257*** 2.069*** 2.579*** 2.045*** 2.086***
TIME (var(u1i) = σ11) 0.078*** 0.541*** 0.534*** 0.532***
TIME*TIME (var(u2i)=σ22) 0.008*** 0.008*** 0.008***
Akaike's information criteria 1,875.8 1,769.8 1,566.4 1,544.0 1,539.6
Schwarz's information criteria 1,883.5 1,785.4 1,592.4 1,580.4 1,578.6
NIN, noninfectious group; SPT, septic group; SSM, shock and multiple organ dysfunction syndrome group; SEP = effect of septic category; DG 
= diagnosis effect. *P < 0.05; ***P < 0.001; NS, not significant; NS/EX, not significant and excluded.Critical Care    Vol 11 No 3    Kyr et al.
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Unfortunately, none of these studies used multilevel modeling
for the statistical analysis, which could have been beneficial in
the evaluation of dynamic changes in proinflammatory
markers.
In our study, we demonstrated that, over time, septic condition
and trauma influence CRP blood levels in children. Hence,
comparison of CRP and other proinflammatory markers such
as PCT can be difficult because of their different kinetics and
because of the heterogeneity among participants (for example,
different medical and surgical conditions) in different studies.
Even obtaining blood levels of both markers at the same time
point would therefore, in the clinical sense, result in different
values. In our study, we found only a weak correlation (R =
0.34, P = not significant) between CRP and PCT blood levels,
supporting these ideas. This comparison was performed on a
limited group of 20 patients with available data for both CRP
and PCT blood levels at the same time points. Similar findings,
in the context of time and different stimuli resulting in PCT
elevation, may be apparent from other studies [25,26]. In
designing similar studies, therefore, the dynamics of different
markers as well as various factors stimulating immune
response should be accounted for to improve the diagnostic
and prognostic values of these markers.
Sources of variability
The presented findings raise questions about causes. We
believe that, in patients with septic shock or MODS, the stim-
ulus inducing CRP production lasts longer. The decrease in
CRP levels is therefore slower in these patients. Other factors
in addition to shock and organ dysfunction, however, may
cause the prolonged elevation of CRP (for example, higher risk
of secondary infection or difficult elimination of present infec-
tion in these severe conditions), and these still remain to be
explored. The SSM included four patients with cancer, a factor
that may also play a role [16]. On the other hand, in septic
patients – in whom we assume that infection is the main factor
inducing CRP production – CRP levels can quickly drop after
successful treatment. These considerations are consistent
with the physiology of the immune response [27,28]. The addi-
tional increase of CRP in surgical patients indicates that
another factor influences CRP production. With respect to our
findings, traumatic insult or surgical intervention may cause
increased CRP production; within the 10-day time period in
this study, the increased production was constant over time
(on logarithmically transformed data).
Comparing the variances in the two final models with the
unconditional growth model, we can see that including either
the septic category as a predictor (model A) or the septic cat-
egory with diagnosis as predictors (model B) both reduces the
variability of baseline CRP values and their rates of change by
about 20% and 1.5%, respectively. Because the variation
remains significant in both models, other predictors still remain
to be found.
Usefulness of the modeling approach
Various diagnoses of patients included in our sample as well
as other factors introducing heterogeneity into the sample (for
example, age, localization of infection, and so on) preclude the
model itself from a direct clinical use. This was not, however,
the main goal. We particularly wanted to show a new method
for analyzing longitudinal data such as these, and how to inter-
pret the results. Other methods and/or models might be used
but we consider the presented models both easy and suffi-
ciently informative.
Limitations
As mentioned above, other predictors could possibly explain
another part of the remaining variation or the overall variance
more comprehensively. These other predictors could be age,
sex, more specifically categorized diagnosis, localization of
Table 6
Equations for the two full models for respective septic and diagnosis categories
Model A
NIN category ln(CRP) = 2.327 + 0.483*TIME - 0.079*TIME*TIME
SPT category ln(CRP) = 2.327 + 1.415 + 0.483*TIME - 0.113*TIME - 0.079*TIME*TIME
SSM category ln(CRP) = 2.327 + 1.029 + 0.483*TIME + 0.101*TIME - 0.079*TIME*TIME
Model B
NIN nonsurgical category ln(CRP) = 1.83 + 0.471*TIME - 0.078*TIME*TIME
NIN surgical category ln(CRP) = 1.83 + 0.661 + 0.471*TIME - 0.078*TIME*TIME
SPT nonsurgical category ln(CRP) = 1.83 + 1.762 + 0.471*TIME - 0.104*TIME - 0.078*TIME*TIME
SPT surgical category ln(CRP) = 1.83 + 1.762 + 0.661 + 0.471*TIME - 0.104*TIME - 0.078*TIME*TIME
SSM nonsurgical category ln(CRP) = 1.83 + 1.402 + 0.471*TIME + 0.109*TIME - 0.078*TIME*TIME
SSM surgical category ln(CRP) = 1.83 + 1.402 + 0.661 + 0.471*TIME + 0.109*TIME - 0.078*TIME*TIME
CRP = C-reactive protein; NIN = noninfectious group; SPT = septic group; SSM = shock and multiple organ dysfunction syndrome group.Available online http://ccforum.com/content/11/3/R70
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infection, more accurately defined organ dysfunction (Sequen-
tial Organ Failure Assessment score), and possibly other fac-
tors. We could not perform a more precise analysis based on
the abovementioned factors because of the relatively small
patient groups; patient numbers in each category would have
been quite small, making a correct, unbiased analysis
impossible.
As Figure 1 shows, CRP levels (in some patients) remain ele-
vated or are even increased in the septic group. This phenom-
enon could have been caused by secondary infection,
insufficiency of diagnostic criteria or eligibility criteria for the
study, or other unknown reasons. Moreover, many patients
had incomplete data records, as shown by short lines in Figure
1. These factors could lead to a decreased accuracy of the
models used. On the other hand, by knowing these negatively
acting factors as well as other important predictors, we may
arrive at more accurate models with more precise predictive
capability.
From the statistical point of view, a different model to that pre-
sented (linear with a quadratic term) may be more suitable; for
example, a nonlinear model. But we think the simpler linear
model we presented here is easier to interpret and, consider-
ing the research questions, is sufficient for analyzing the data.
Another problem, however, arises from the data. We can see
that the numbers in some patient groups are quite small. We
had to deal with the data we had available. There were no more
patients in the most severe category (fortunately for the
patients). The estimates, however, can be biased by this fact.
To be somewhat sure of the results, we performed the follow-
ing procedure. We performed the analysis without both
effects (SEP, DG) together; that is, we performed the analysis
separately with SEP (which is actually model A) and DG, and
based on these analyses we could draw the same conclusions
concerning SEP and DG as we already had done.
Since the analysis was intended as exploratory, we consider
the results sufficiently clear. To explore the variance heteroge-
neity we performed the M Box test, which tests the homoge-
neity of a covariance matrix [29]. This test was performed on a
restricted group of patients with sufficient data in the first six
time points (41 subjects in four groups) and we obtained P =
0.132. We could not perform the test in all groups due to the
lack of the data but we think that the model analyses pre-
sented here could be performed assuming that the covariance
matrix did not significantly differ among the analyzed groups.
Since the analysis was performed on the whole sample data
collected, the model needs a validation set for model
validation. The present paper, however, was intended only as
an exploratory analysis that should give the first insight into the
data.
Because the study was retrospective, and due to the limita-
tions mentioned above, we intend to perform a prospective
study to verify these findings in a larger cohort of patients.
Nevertheless, this study poses novel considerations based on
simple monitoring of dynamic changes of blood CRP levels in
children with sepsis, with results that prove worthy of further
investigation.
Conclusion
Our results suggest that the more severe the systemic reac-
tion to the insult, the higher and the more prolonged the CRP
levels. Moreover, in patients with the most severe conditions,
such as septic shock and MODS, the rate of decrease of CRP
levels was less rapid than in common septic patients. We
demonstrated that septic patients after trauma or surgical
intervention have higher CRP levels compared with patients
with other diagnoses. Following the overall dynamics of CRP,
blood levels can improve the prognostic and diagnostic value
of CRP as a marker of sepsis severity compared with consid-
eration of its values separately at single time points. In conclu-
sion, multilevel modeling is a novel technique for analyzing
longitudinal data that can be applied successfully in CRP level
monitoring.
Figure 2
Model curves Model curves. Predicted C-reactive protein (CRP) level curves of (left) model A and (right) model B. ▲, Noninfectious group; ■, septic group; and 
●, shock and multiple organ dysfunction syndrome group. Model B: nonsurgical patients (dashed lines) and surgical patients (solid lines) conditions.Critical Care    Vol 11 No 3    Kyr et al.
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